Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000953954 | SCV001100555 | likely benign | Cystic fibrosis | 2024-02-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000953954 | SCV002718658 | likely benign | Cystic fibrosis | 2015-03-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV000953954 | SCV001455984 | uncertain significance | Cystic fibrosis | 2018-09-29 | no assertion criteria provided | clinical testing |